Healthcare >> CEO Interviews >> September 30, 1999

Frank Baldino Jr. – Cephalon Inc (ceph)

FRANK BALDINO, JR., founded Cephalon, Inc., in 1987 and serves as Chairman of the Board and Chief Executive Officer of the company. Dr. Baldino has nearly two decades of scientific experience in Neurobiology, Molecular Biology and Electrophysiology, and has authored more than 100 publications in peer-reviewed journals such as Nature, Journal of Neuroscience Research and Brain Research. Dr. Baldino received his PhD in Pharmacology from Temple University. From 1981-1987, Dr. Baldino served as Senior Research Biologist in the Medical Products department at E.I. Dupont de Nemours & Company. He currently serves as a Director of NicOx, S.A., ViroPharma, Inc., Pharmacopeia, Inc., the Jackson Laboratory, the Biotechnology Industry Organization (BIO), and Acusphere, Inc. He holds several adjunct academic appointments, including Adjunct Professor of Pharmacology at Temple University Medical School, Adjunct Professor of Physiology and Biophysics and Adjunct Professor of Neurology at Hahnemann University Hospital. Profile
TWST: Let's start out by your giving us a brief overview of Cephalon,

Inc., the company's history, products, activities, those kinds of


Mr. Baldino: Cephalon is a 12-year old company